High Molecular Weight Proteinoids for Targeted Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current proteinoid compounds for drug delivery systems have broad molecular weight distribution and low stability, which limits their effectiveness in targeting tumors and reducing toxicity.
Innovation Solution
Development of high molecular weight proteinoid compounds (at least 15,000 Da) with low dispersity, composed of specific amino acids and polyesters, prepared through thermal random condensation polymerization, allowing for improved stability and targeted drug delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If thermal random condensation polymerization is used to prepare proteinoid compounds, then the production process is simple and fast, but the molecular weight distribution is broad and molecular weight control is poor
Solution Approach 1:
The patent applies parameter changes by optimizing the polymerization temperature (110-150°C), reaction time (1-24 hours), and amino acid concentration (0.1-1.0 M) to control the molecular weight and dispersity of proteinoid compounds. By carefully adjusting these parameters, the invention achieves high molecular weight (≥15,000 Da) with low dispersity (≤1.2) while maintaining the simplicity of thermal condensation polymerization
Solution Approach 2:
The invention creates composite proteinoid structures by combining multiple amino acids (e.g., phenylalanine, glutamic acid, lysine, arginine) in specific ratios to form copolymerized proteinoid compounds. This composite approach allows control over molecular weight and dispersity while maintaining the advantages of thermal condensation polymerization
2Reliability
If low molecular weight proteinoids (250-2400 Da) are used as carriers, then they are soluble in selected pH ranges and stable, but they have limited drug delivery effectiveness and high toxicity
Solution Approach 1:
The patent segments the proteinoid structure into controlled molecular weight ranges (≥15,000 Da) with low dispersity, creating uniform polymeric chains that reduce toxicity while maintaining stability. The segmentation principle is applied by controlling the degree of polymerization to achieve optimal molecular weight for tumor targeting and reduced systemic toxicity
Solution Approach 2:
The invention changes the molecular weight parameter from low (250-2400 Da) to high (≥15,000 Da) while controlling dispersity (≤1.2), fundamentally altering the biological properties of proteinoids to reduce toxicity and improve tumor accumulation without sacrificing pH-dependent solubility and stability
3Ease of manufacture
If broad molecular weight distribution proteinoids are used, then they can be easily prepared, but they show poor selective tumor accumulation and low therapeutic index
Solution Approach 1:
The patent applies parameter changes by optimizing reaction conditions (temperature, time, concentration) to achieve narrow molecular weight distribution (dispersity ≤1.2) while maintaining the simplicity of thermal condensation polymerization. This resolves the contradiction by showing that manufacturing precision can be improved without sacrificing ease of manufacture
4Reliability
If high molecular weight proteinoids (≥15,000 Da) with low dispersity are prepared, then stability and tumor targeting are improved, but the preparation process requires precise control
Solution Approach 1:
The patent demonstrates that by optimizing specific parameters (temperature 110-150°C, time 1-24 hours, concentration 0.1-1.0 M), high molecular weight proteinoids with low dispersity can be prepared through simple thermal condensation polymerization. The process control complexity is minimized by identifying and controlling only the key parameters that influence molecular weight and dispersity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The high molecular weight proteinoid compounds achieve enhanced stability and selective tumor accumulation, improving therapeutic index and reducing toxicity, while maintaining biocompatibility and biodegradability.
Implementation Method 1
Proteinoids comprise small poly(amino acid) polymers prepared by thermal random condensation polymerization of various α-amino acids
Data Source
AI summary
Proteinoid compounds characterized by a molecular weight (Mw) of at least 15,000 Da, processes of preparing such compounds and methods of use thereof, are provided. A method of monitoring the presence and metastases of cancer in a body of an individual is further disclosed.